Vontobel Holding’s Moderna MRNA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-1,500
Closed -$44.2K 1382
2025
Q4
$44.2K Hold
1,500
﹤0.01% 1410
2025
Q3
$38.7K Buy
1,500
+300
+25% +$8.37K ﹤0.01% 1334
2025
Q2
$33.1K Buy
+1,200
New +$31.6K ﹤0.01% 1249

Other funds holding MRNA

Vontobel Holding's MRNA Position: Q1 2026 in Review

Vontobel Holding increased its Moderna (MRNA) stake by 23% in Q1 2026, buying an estimated $1.4M and bringing the position to 163,422 shares worth $8.3M. The position accounts for 0.03% of the portfolio, ranked #284.

Vontobel Holding first reported a position in MRNA in Q4 2020 and has held it in 22 quarters since. The position peaked at $48.9M in Q3 2021. 722 funds tracked by Wall St. Rank hold MRNA as of Q1 2026.

  • Vontobel Holding held 163,422 shares of Moderna worth $8.3M as of Q1 2026.
  • Vontobel Holding bought 30,094 Moderna shares in Q1 2026, an estimated $1.4M.
  • Moderna made up 0.03% of Vontobel Holding's portfolio in Q1 2026, its #284 holding.
  • Vontobel Holding first reported a position in Moderna in Q4 2020 and has held it in 22 quarters since.
  • Vontobel Holding's Moderna position peaked at $48.9M in Q3 2021.
  • 722 funds tracked by Wall St. Rank held Moderna as of Q1 2026.

Based on Vontobel Holding's 13F filing for Q1 2026, filed 8 May 2026.